osteoporosis (Steve Darby) Flashcards
What is osteoporosis?
loss of bone mass due to reduced organic bone matrix and mineral content
causes of osteoporosis
increased bone resorption (osteoclasts)
decreased bone formation (osteoblasts)
both
causes of primary osteoporosis
menopause (inc bone resorption) age associated (dec bone formation)
causes of secondary osteoporosis
drug/disease induced
- severe malnutrition (anorexia, lack of Vit D)
- endocrine (hypogonadism, hyperparathyroidism)
- cancer
- drug use
What hormones control the homeostatic regulation of Ca?
calcitonin
PTH
Vit D
RANKL
receptor activated NF kappa B ligand
How does an osteoclast precursor become an active osteoclast?
pre-osteoclast has RANK (receptor) on its surface
PTH stimulates release of RANKL
RANKL binds to RANK
causes the osteoclast precursor to become active
these then degrade bone
What is bone resorption?
degradation of bone
What substances cause bone resorption (degradation)?
RANKL
PTH
What is OPG?
oseteoprotegerin
What does OPG do?
inhibits bone resorption
How does inhibition of bone resorption occur?
bone releases OPG (oesteoprotegerin)
OPG binds to RANKL
this prevents RANKL from binding to RANK on the osteoclast precursor
How do oestrogens help in bone formation?
promote formation of pre-osteoblasts
prevent activation of T cells (T cells release RANKL)
prevent generaion of osteoclasts
What happens when oestrogen levels are decreased?
T cells become activated
RANKL increased (from T cells)
activates pre-osteoclasts, inc in bone resportion - bone loss
preventative measures for osteoporosis
- oral Ca supplements (inc BMD in spine in postmenopause)
- Vit D
- HRT in peri/post menopause
- smoking cessation
- increased exercise (promotes bone remodelling)
pharmacological treament options for osteoporosis
bisphosphonates denosumab HRT raloxifene teriparatide
2 types of therapies for established osteoporosis
- anti-resorptive therapies - dec markers of bone formation and bone resorption
bisphosphonates, raloxifene, oestrogen, denosumab - bone forming therapies (anabolic) - inc markers of bone formation over bone resorption
calcitonin, teriparatide
composition of calcified bone
25% organic matrix
5% water
70% hydroxyapatite
What is hydroxyapetite?
crystalline complex of Ca and P
What does pyrophosphate do?
binds and stabilises Ca and P in bone
Why can’t pyrophosphate be given orally?
it’s hydrolyses in GIT
ester bond broken into 2 phosphate groups
difference between pyrophosphate and bisphosphonates?
oxygen replaced with a carbon with 2 functional groups
P-C-P can’t be hydrolysed
R1 side chain of bisphosphonates
hydroxyl group
- maximises effects to bind hydroxyapatite
- increases Ca affinity
R2 side chain on bisphosphonates
amino residue
- increaes potency
How do bisphosphonates work?
- stabilise the hydroxyapatite matrix
- inhibit bone resorption
- inhibit osteoclast proliferation
- inhibit osteoclast activity
- inhibit malaveonate pathway -> to regulate osteoclast fxn
- > reduce bone turnover and allow osteoblasts to function